Nissan North America, Inc.
Summary
NHTSA campaign 23V108: Nissan North America, Inc. recalled for a safety defect. A seat that becomes stuck or fails to lock in a secured position may not properly restrain the occupant during a crash,
Details
Source
nhtsa
External ID
23V108
Action Date
2023-02-22
Status
Ongoing
Category
vehicle
Product Description
Nissan North America, Inc. (Nissan) is recalling certain 2023 Infiniti QX60 vehicles. The second-row adjustable seat may extend past the intended rear stopper point and may be difficult to move, become stuck, or fail to lock in the correct position.
Company
Context & Analysis
Nissan North America, Inc. has 85 FDA actions in our database.
Frequently Asked Questions
How often does Nissan North America, Inc. have FDA actions?
Nissan North America, Inc. has 85 FDA actions in our database, including 0 recalls and 0 device clearances.
Where can I find the official FDA record?
The official record is available on FDA.gov. Use the link above to view the complete official filing. You can also use the openFDA API to query this record programmatically.
Want to know the moment something like this happens?
Get alerts for vehicle